Nanostructured lipid carrier (NLC) based gel of celecoxib

被引:232
作者
Joshi, Medha [1 ]
Patravale, Vandana [1 ]
机构
[1] Inst Chem Technol, Dept Pharmaceut Sci & Technol, Bombay 400019, Maharashtra, India
关键词
celecoxib; nanosturctured lipid carriers (NLC); topical gels; micellar; anti-inflammatory; prolonged action;
D O I
10.1016/j.ijpharm.2007.05.060
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanostructured lipid carriers (NLC) based topical gel of celecoxib was formulated for the treatment of inflammation and allied conditions. NLC prepared by the microemulsion template technique were characterized by photon correlation spectroscopy for size and scanning electron micrograph (SEM) studies. Drug encapsulation efficiency was determined using Nanosep (R) centrifugal device. The nanoparticulate dispersion was suitably gelled and assessed for in vitro release and in vitro skin permeation using rat skin. Efficacy of the NLC gel was established using a pharmacodynamic study, i.e., aerosil-induced rat paw edema model. The skin permeation and rat paw edema pharmacodynamic studies were carried out in comparison with a micellar gel which had the same composition as that of the NLC gel except for the solid lipid and oil. The NLC based gel described in this study showed faster onset and elicited prolonged activity until 24 h. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 47 条
[1]  
[Anonymous], 1977, MICROEMULSIONS THEOR
[2]   Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy [J].
Borgia, SL ;
Regehly, M ;
Sivaramakrishnan, R ;
Mehnert, W ;
Korting, HC ;
Danker, K ;
Röder, B ;
Kramer, KD ;
Schäfer-Korting, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 110 (01) :151-163
[3]   Preparation of solid lipid nanoparticles using a membrane contactor [J].
Charcosset, C ;
El-Harati, A ;
Fessi, H .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (01) :112-120
[4]   A stability-indicating HPLC method to determine celecoxib in capsule formulations [J].
Dhabu, PM ;
Akamanchi, KG .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (07) :815-821
[5]   Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor [J].
El-Harati, Assma Ahmed ;
Charcosset, Catherine ;
Fessi, Hatem .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2006, 11 (02) :153-157
[6]  
Gasco M.R., 1997, PHARM TECHNOL EUR, V9, P52
[7]  
Gasco M. R, 1993, US Patent, Patent No. [5 250 236, 5250236]
[8]   A novel phase inversion-based process for the preparation of lipid nanocarriers [J].
Heurtault, B ;
Saulnier, P ;
Pech, B ;
Proust, JE ;
Benoit, JP .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :875-880
[9]   Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization [J].
Hu, FQ ;
Yuan, H ;
Zhang, HH ;
Fang, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :121-128
[10]   Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery [J].
Jain, SK ;
Chourasia, MK ;
Masuriha, R ;
Soni, V ;
Jain, A ;
Jain, NK ;
Gupta, Y .
DRUG DELIVERY, 2005, 12 (04) :207-215